选择性5-羟色胺再摄取抑制剂治疗帕金森病伴发的抑郁 - Suppr

Suppr

超能文献

SSRIs in the treatment of depression in Parkinson's disease.

作者信息

Leentjens A F G, Vreeling F W, Luijckx G-J, Verhey F R J

机构信息

Department of Psychiatry, Maastricht University Hospital, Maastricht, The Netherlands.

出版信息

Int J Geriatr Psychiatry. 2003 Jun;18(6):552-4. doi: 10.1002/gps.865.

DOI:10.1002/gps.865

PMID:12789682

Abstract

摘要

相似文献

SSRIs in the treatment of depression in Parkinson's disease.

Int J Geriatr Psychiatry. 2003 Jun;18(6):552-4. doi: 10.1002/gps.865.

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

Clin Neuropharmacol. 2001 Jul-Aug;24(4):221-7. doi: 10.1097/00002826-200107000-00005.

Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram.

Int Clin Psychopharmacol. 1998 Sep;13(5):205-11. doi: 10.1097/00004850-199809000-00003.

Treatment of postpsychotic depression with sertraline in patients with schizophrenia.

Bratisl Lek Listy. 2006;107(8):290-1.

[Depression in Parkinson's disease].

Presse Med. 2009 Jun;38(6):869-71. doi: 10.1016/j.lpm.2008.12.017. Epub 2009 Jan 21.

[Treatment of comorbid obsessive-compulsive and depressive disorders in children age].

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(11 Pt 2):48-52.

Relapse of depressive symptoms after discontinuing sertraline.

JAMA. 1999 Jul 28;282(4):323-4. doi: 10.1001/jama.282.4.323.

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.

Biol Psychiatry. 2000 Nov 1;48(9):894-901. doi: 10.1016/s0006-3223(00)00957-4.

Early augmentation of sertraline with methylphenidate.

J Clin Psychiatry. 1999 Feb;60(2):123-4. doi: 10.4088/jcp.v60n0210c.

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Neurology. 2012 Apr 17;78(16):1229-36. doi: 10.1212/WNL.0b013e3182516244. Epub 2012 Apr 11.

引用本文的文献

Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis.

Br J Psychiatry. 2025 Apr 4:1-14. doi: 10.1192/bjp.2025.18.

Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Clin Drug Investig. 2024 Jul;44(7):459-469. doi: 10.1007/s40261-024-01378-8. Epub 2024 Jul 3.

Serotonin as a biomarker of toxin-induced Parkinsonism.

Mol Med. 2024 Mar 1;30(1):33. doi: 10.1186/s10020-023-00773-9.

Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson's disease: a case report.

BMC Geriatr. 2023 Jun 1;23(1):344. doi: 10.1186/s12877-023-04057-z.

Depression in Parkinson's Disease: A Narrative Review.

Cureus. 2022 Aug 7;14(8):e27750. doi: 10.7759/cureus.27750. eCollection 2022 Aug.

Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Drugs Aging. 2022 Jun;39(6):417-439. doi: 10.1007/s40266-022-00942-1. Epub 2022 Jun 16.

Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.

Int J Geriatr Psychiatry. 2018 Apr;33(4):642-651. doi: 10.1002/gps.4834. Epub 2017 Dec 13.

Neuropsychiatric Issues in Parkinson's Disease.

Curr Neurol Neurosci Rep. 2016 May;16(5):49. doi: 10.1007/s11910-016-0647-4.

Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.

P T. 2015 Dec;40(12):838-46.

Monoamine reuptake inhibitors in Parkinson's disease.

Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

SSRIs in the treatment of depression in Parkinson's disease.

作者信息

Leentjens A F G, Vreeling F W, Luijckx G-J, Verhey F R J

机构信息

Department of Psychiatry, Maastricht University Hospital, Maastricht, The Netherlands.

出版信息

Int J Geriatr Psychiatry. 2003 Jun;18(6):552-4. doi: 10.1002/gps.865.

DOI:10.1002/gps.865

PMID:12789682

Abstract

摘要

相似文献

SSRIs in the treatment of depression in Parkinson's disease.

Int J Geriatr Psychiatry. 2003 Jun;18(6):552-4. doi: 10.1002/gps.865.

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

Clin Neuropharmacol. 2001 Jul-Aug;24(4):221-7. doi: 10.1097/00002826-200107000-00005.

Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram.

Int Clin Psychopharmacol. 1998 Sep;13(5):205-11. doi: 10.1097/00004850-199809000-00003.

Treatment of postpsychotic depression with sertraline in patients with schizophrenia.

Bratisl Lek Listy. 2006;107(8):290-1.

[Depression in Parkinson's disease].

Presse Med. 2009 Jun;38(6):869-71. doi: 10.1016/j.lpm.2008.12.017. Epub 2009 Jan 21.

[Treatment of comorbid obsessive-compulsive and depressive disorders in children age].

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(11 Pt 2):48-52.

Relapse of depressive symptoms after discontinuing sertraline.

JAMA. 1999 Jul 28;282(4):323-4. doi: 10.1001/jama.282.4.323.

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.

Biol Psychiatry. 2000 Nov 1;48(9):894-901. doi: 10.1016/s0006-3223(00)00957-4.

Early augmentation of sertraline with methylphenidate.

J Clin Psychiatry. 1999 Feb;60(2):123-4. doi: 10.4088/jcp.v60n0210c.

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Neurology. 2012 Apr 17;78(16):1229-36. doi: 10.1212/WNL.0b013e3182516244. Epub 2012 Apr 11.

引用本文的文献

Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis.

Br J Psychiatry. 2025 Apr 4:1-14. doi: 10.1192/bjp.2025.18.

Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Clin Drug Investig. 2024 Jul;44(7):459-469. doi: 10.1007/s40261-024-01378-8. Epub 2024 Jul 3.

Serotonin as a biomarker of toxin-induced Parkinsonism.

Mol Med. 2024 Mar 1;30(1):33. doi: 10.1186/s10020-023-00773-9.

Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson's disease: a case report.

BMC Geriatr. 2023 Jun 1;23(1):344. doi: 10.1186/s12877-023-04057-z.

Depression in Parkinson's Disease: A Narrative Review.

Cureus. 2022 Aug 7;14(8):e27750. doi: 10.7759/cureus.27750. eCollection 2022 Aug.

Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Drugs Aging. 2022 Jun;39(6):417-439. doi: 10.1007/s40266-022-00942-1. Epub 2022 Jun 16.

Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.

Int J Geriatr Psychiatry. 2018 Apr;33(4):642-651. doi: 10.1002/gps.4834. Epub 2017 Dec 13.

Neuropsychiatric Issues in Parkinson's Disease.

Curr Neurol Neurosci Rep. 2016 May;16(5):49. doi: 10.1007/s11910-016-0647-4.

Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.

P T. 2015 Dec;40(12):838-46.

Monoamine reuptake inhibitors in Parkinson's disease.

Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25.